DOCUSATE SODIUM  - docusate sodium tablet, film coated 
Gemini Pharmaceuticals, Inc. dba ONDRA Pharmaceuticals

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Active Ingredient

Docusate Sodium 100mg

Purpose

Stool Softener

Uses

Warnings


Do not use

  • laxative products for longer than one week unless directed to do so by a doctor
  • if you are presently taking mineral oil unless told to do so by a doctor

Ask a doctor before use if you have

  • stomach pain
  • nausea
  • vomiting
  • noticed  a sudden change in bowel habits that last over 2 weeks

Stop use and ask a doctor if

  • you have rectal bleeding
  • you fail to have a bowel movement after use these could be signs of a serious condition.

If pregnant or breast-feeding

ask a doctor before use

Keep out of reach of Children

In case of overdose, get medical help or contact a poison control center right away.

Directions

Adults and children 12 years of age and older:Take 1 tablet as needed, not to exceed more than 3 tablets daily, or as directed by a doctor
Children under 12 years of ageConsult a doctor before use.

Other information

Inactive ingredients

Croscarmellose Sodium, Dicalcium Phosphate, Hypromellose, Magnesium Stearate, Microcrystalline Cellulose, Polyethylene Glycol, Pregelatinized Starch, Silica, Sodium Benzoate, Stearic acid.

Questions?

If you have any questions or comments or to report an adverse event please contact 1-800-medline

Principal Display Panel

ONDRA Pharmaceuticals
Docusate Sodium 100mg
Stool Softener
Relieves Occasional (Irregularity)
compare to active ingredient in COLACE®
This product is not manufactured or distributed by Purdue Products,LP.,owner of the registerd trademark Colace®
100  Tablets 100mg Each
Untitled.jpg

DOCUSATE SODIUM 
docusate sodium tablet, film coated
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:51645-606
Route of AdministrationORALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
DOCUSATE SODIUM (DOCUSATE) DOCUSATE SODIUM100 mg
Inactive Ingredients
Ingredient NameStrength
CROSCARMELLOSE SODIUM 
ANHYDROUS DIBASIC CALCIUM PHOSPHATE 
HYPROMELLOSES 
MAGNESIUM STEARATE 
CELLULOSE, MICROCRYSTALLINE 
POLYETHYLENE GLYCOL 
STARCH, CORN 
SILICON DIOXIDE 
SODIUM BENZOATE 
STEARIC ACID 
Product Characteristics
ColorwhiteScore2 pieces
ShapeROUND (Round Biconvex) Size11mm
FlavorImprint Code GPI;S1
Contains    
Packaging
#Item CodePackage DescriptionMultilevel Packaging
1NDC:51645-606-01100 TABLET, FILM COATED ( TABLET) in 1 BOTTLE, PLASTICNone

Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph not finalpart33403/30/2012

Labeler - Gemini Pharmaceuticals, Inc. dba ONDRA Pharmaceuticals (055942270)

Revised: 03/2012 Gemini Pharmaceuticals, Inc. dba ONDRA Pharmaceuticals